PE20020969A1 - Sal de tiazolidindiona y sus polimorfos como agentes antidiabeticos y procedimiento para la obtencion de los mismos - Google Patents
Sal de tiazolidindiona y sus polimorfos como agentes antidiabeticos y procedimiento para la obtencion de los mismosInfo
- Publication number
- PE20020969A1 PE20020969A1 PE2002000054A PE2002000054A PE20020969A1 PE 20020969 A1 PE20020969 A1 PE 20020969A1 PE 2002000054 A PE2002000054 A PE 2002000054A PE 2002000054 A PE2002000054 A PE 2002000054A PE 20020969 A1 PE20020969 A1 PE 20020969A1
- Authority
- PE
- Peru
- Prior art keywords
- procedure
- obtaining
- antidiabetic agents
- salt
- thiazolidindiona
- Prior art date
Links
- 229940125708 antidiabetic agent Drugs 0.000 title abstract 2
- 239000003472 antidiabetic agent Substances 0.000 title abstract 2
- 150000003839 salts Chemical class 0.000 title 1
- 229940077274 Alpha glucosidase inhibitor Drugs 0.000 abstract 1
- 229940123208 Biguanide Drugs 0.000 abstract 1
- XNCOSPRUTUOJCJ-UHFFFAOYSA-N Biguanide Chemical compound NC(N)=NC(N)=N XNCOSPRUTUOJCJ-UHFFFAOYSA-N 0.000 abstract 1
- 208000031226 Hyperlipidaemia Diseases 0.000 abstract 1
- 229940100389 Sulfonylurea Drugs 0.000 abstract 1
- 239000003888 alpha glucosidase inhibitor Substances 0.000 abstract 1
- 229940125388 beta agonist Drugs 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000000843 powder Substances 0.000 abstract 1
- NOJNFULGOQGBKB-UHFFFAOYSA-M sodium;3-[3-tert-butylsulfanyl-1-[[4-(6-ethoxypyridin-3-yl)phenyl]methyl]-5-[(5-methylpyridin-2-yl)methoxy]indol-2-yl]-2,2-dimethylpropanoate Chemical compound [Na+].C1=NC(OCC)=CC=C1C(C=C1)=CC=C1CN1C2=CC=C(OCC=3N=CC(C)=CC=3)C=C2C(SC(C)(C)C)=C1CC(C)(C)C([O-])=O NOJNFULGOQGBKB-UHFFFAOYSA-M 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Endocrinology (AREA)
- Cardiology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Emergency Medicine (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Abstract
SE REFIERE A UNA SAL SODICA DE LA 5-(4-{2-[(6-METOXI-PIRIMIDIN-4-IL)-METIL-AMINO]-ETOXI}-BENCIL)-TIAZOLIDIN-2,4-DIONA CARACTERIZADO POR DIFRACTOGRAMA DE RAYOS X DE POLVO. SE REFIERE TAMBIEN A UN PROCEDIMIENTO PARA LA OBTENCION Y UNA COMPOSICION FARMACEUTICA. EL COMPUESTO MENCIONADO EN COMBINACION CON AGENTES ANTIDIABETICOS COMO SULFONILUREAS, BIGUANIDAS, INHIBIDORES DE ALFAGLUCOSIDASA, AGONISTAS BETA SON UTILES PARA EL TRATAMIENTO DE HIPERGLICEMIA, HIPERLIPIDEMIA
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES200100273A ES2174748B1 (es) | 2001-01-31 | 2001-01-31 | Nueva sal de tiazolidindiona y sus polimorfos como agentes antidiabeticos y procedimiento para la obtencion de los mismos. |
Publications (1)
Publication Number | Publication Date |
---|---|
PE20020969A1 true PE20020969A1 (es) | 2002-12-04 |
Family
ID=8496644
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE2002000054A PE20020969A1 (es) | 2001-01-31 | 2002-01-24 | Sal de tiazolidindiona y sus polimorfos como agentes antidiabeticos y procedimiento para la obtencion de los mismos |
Country Status (27)
Country | Link |
---|---|
US (1) | US20040106632A1 (es) |
EP (1) | EP1355908A1 (es) |
JP (1) | JP2004529870A (es) |
KR (1) | KR20030078893A (es) |
CN (1) | CN1694881A (es) |
AP (1) | AP1281A (es) |
AR (1) | AR042584A1 (es) |
BG (1) | BG108047A (es) |
BR (1) | BR0206850A (es) |
CA (1) | CA2436556A1 (es) |
CZ (1) | CZ20032015A3 (es) |
EA (1) | EA200300842A1 (es) |
EE (1) | EE200300356A (es) |
ES (1) | ES2174748B1 (es) |
HU (1) | HUP0302871A2 (es) |
IL (1) | IL157028A0 (es) |
IS (1) | IS6896A (es) |
MA (1) | MA26988A1 (es) |
MX (1) | MXPA03006722A (es) |
NO (1) | NO20033375L (es) |
NZ (1) | NZ527677A (es) |
PE (1) | PE20020969A1 (es) |
PL (1) | PL362527A1 (es) |
SK (1) | SK9552003A3 (es) |
WO (1) | WO2002060899A1 (es) |
YU (1) | YU60303A (es) |
ZA (1) | ZA200305873B (es) |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0842925A1 (en) * | 1987-09-04 | 1998-05-20 | Beecham Group Plc | Substituted thiazolidinedione derivatives |
CN1183130C (zh) * | 1999-09-24 | 2005-01-05 | 中国人民解放军军事医学科学院毒物药物研究所 | 噻唑烷类衍生物及其医药用途 |
ES2156574B1 (es) * | 1999-11-18 | 2002-02-01 | Vita Invest Sa | Nuevos derivados de tiazolidindiona como agentes antidiabeticos |
-
2001
- 2001-01-31 ES ES200100273A patent/ES2174748B1/es not_active Expired - Fee Related
-
2002
- 2002-01-21 US US10/470,980 patent/US20040106632A1/en not_active Abandoned
- 2002-01-21 KR KR10-2003-7009880A patent/KR20030078893A/ko not_active Application Discontinuation
- 2002-01-21 WO PCT/IB2002/000229 patent/WO2002060899A1/en not_active Application Discontinuation
- 2002-01-21 MX MXPA03006722A patent/MXPA03006722A/es not_active Application Discontinuation
- 2002-01-21 EA EA200300842A patent/EA200300842A1/ru unknown
- 2002-01-21 PL PL02362527A patent/PL362527A1/xx not_active Application Discontinuation
- 2002-01-21 BR BR0206850-8A patent/BR0206850A/pt not_active IP Right Cessation
- 2002-01-21 CN CNA028043863A patent/CN1694881A/zh active Pending
- 2002-01-21 CA CA002436556A patent/CA2436556A1/en not_active Abandoned
- 2002-01-21 EP EP02716216A patent/EP1355908A1/en not_active Withdrawn
- 2002-01-21 HU HU0302871A patent/HUP0302871A2/hu unknown
- 2002-01-21 ZA ZA200305873A patent/ZA200305873B/en unknown
- 2002-01-21 JP JP2002561467A patent/JP2004529870A/ja active Pending
- 2002-01-21 NZ NZ527677A patent/NZ527677A/en unknown
- 2002-01-21 CZ CZ20032015A patent/CZ20032015A3/cs unknown
- 2002-01-21 IL IL15702802A patent/IL157028A0/xx unknown
- 2002-01-21 SK SK955-2003A patent/SK9552003A3/sk not_active Application Discontinuation
- 2002-01-21 EE EEP200300356A patent/EE200300356A/xx unknown
- 2002-01-21 AP APAP/P/2003/002832A patent/AP1281A/en active
- 2002-01-21 YU YU60303A patent/YU60303A/sh unknown
- 2002-01-24 PE PE2002000054A patent/PE20020969A1/es not_active Application Discontinuation
- 2002-01-28 AR ARP020100291A patent/AR042584A1/es not_active Application Discontinuation
-
2003
- 2003-07-28 IS IS6896A patent/IS6896A/is unknown
- 2003-07-28 NO NO20033375A patent/NO20033375L/no not_active Application Discontinuation
- 2003-07-31 MA MA27262A patent/MA26988A1/fr unknown
- 2003-08-01 BG BG108047A patent/BG108047A/bg unknown
Also Published As
Publication number | Publication date |
---|---|
AP1281A (en) | 2004-05-25 |
ZA200305873B (en) | 2004-07-30 |
YU60303A (sh) | 2006-05-25 |
BG108047A (bg) | 2004-08-31 |
BR0206850A (pt) | 2004-01-13 |
EA200300842A1 (ru) | 2004-04-29 |
ES2174748B1 (es) | 2003-09-16 |
NZ527677A (en) | 2005-01-28 |
WO2002060899A1 (en) | 2002-08-08 |
MA26988A1 (fr) | 2004-12-20 |
NO20033375L (no) | 2003-08-22 |
CZ20032015A3 (cs) | 2004-02-18 |
US20040106632A1 (en) | 2004-06-03 |
EP1355908A1 (en) | 2003-10-29 |
MXPA03006722A (es) | 2004-10-15 |
ES2174748A1 (es) | 2002-11-01 |
AP2003002832A0 (en) | 2003-09-30 |
CN1694881A (zh) | 2005-11-09 |
NO20033375D0 (no) | 2003-07-28 |
IL157028A0 (en) | 2004-02-08 |
EE200300356A (et) | 2003-10-15 |
PL362527A1 (en) | 2004-11-02 |
IS6896A (is) | 2003-07-28 |
JP2004529870A (ja) | 2004-09-30 |
KR20030078893A (ko) | 2003-10-08 |
HUP0302871A2 (hu) | 2003-12-29 |
AR042584A1 (es) | 2005-06-29 |
SK9552003A3 (en) | 2004-05-04 |
CA2436556A1 (en) | 2002-08-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR112669A2 (es) | Compuestos inhibidores del cotransportador de sodio y glucosa 2 y compuestos útiles para su preparación | |
PE20080065A1 (es) | Compuestos derivados de bencimidazol como moduladores del receptor vainilloide vr1 | |
AR055112A1 (es) | Fungicidas n-(2-(haloalcoxi) fenil) heteroaril carboxamidas | |
UY29875A1 (es) | Compuestos quimicos | |
PE20060937A1 (es) | Derivados de sulfonilbencimidazol como agonistas del receptor cannabinoide 2 (cb2) | |
PE20090601A1 (es) | Derivados de piridin-il-oxi-piridinas como inhibidores de alk5 | |
PE20060297A1 (es) | Nuevos derivados fluoroglicosidicos de pirazoles como inhibidores de sglt 1 | |
GEP20074148B (en) | Pyrrolo-triazine aniline compounds useful as kinase inhibitors | |
DE60123800D1 (de) | Salze von benzimidazol-derivaten und deren verwendung | |
CY1108573T1 (el) | Ανταγωνιστες νρυυ5 | |
PE20080093A1 (es) | Inhibidores de la replicacion del virus de la inmunodeficiencia humana | |
PE20051054A1 (es) | Compuestos heterociclicos utiles como secretagogos de la hormona de crecimiento | |
BR0110492A (pt) | Composto, composição farmacêutica que compreende esse composto, processo para a preparação de composição farmacêutica, utilização do composto e processo para a preparação do composto | |
CL2011000009A1 (es) | Composicion farmaceutica que comprende un compuesto derivado de (diaza)- u (oxa-aza)-biciclo-octano en combinacion con un antibiotico de beta-lactamina; y el uso de la composicion para inhibir la produccion de beta-lactamasa en una terapia antibacteriana. (divisional de la solicitud 134-2003) | |
SV2008002969A (es) | Derivados de pirimidina para el tratamiento del crecimiento celular anormal | |
ECSP034865A (es) | Resolución óptica de (1-benzilo-4-metilopiperidina-3-il)-metilamina y su uso para la preparación de derivados de pirrolo 2,3-pirimidina como inhibidores de proteina quinasas | |
RS53293B (en) | CYTOTOXIC AGENTS CONTAINING NEW TOMAIMYCIN DERIVATIVES AND THEIR THERAPY | |
AR049578A1 (es) | Derivados de hidantoina, procesos de obtencion y composiciones farmaceuticas | |
AR049274A1 (es) | Acido2-{[2-(2-metilaminopirimidin-4-il)-1h-indol-5-carbonil]amino}-3-(fenilpiridin-2-ilamino)propionico sustancialmente puro como inhibidor selectivo de la quinasa ikk-2 | |
UY29181A1 (es) | Derivados de bencenosulfonamidas n-sustituidos, composiciones que los contienen, procesos de preparación y aplicaciones | |
PE20070122A1 (es) | Proceso para preparar derivados de piperazina azindoloxoacetica sustituida con triazol y nuevas formas de sal producidas de los mismos | |
AR039936A1 (es) | Formulacion farmaceutica de liberacion modificada | |
PE20070829A1 (es) | Inhibidores cetp heterociclicos | |
ECSP078062A (es) | Heterociclos de 1,4-dihidropiridina-condensados, procesos para preparar los mismos, uso y composiciones que los contienen | |
UY27851A1 (es) | Difenilazetidinonas sustituidas en anillo, procedimiento para su preparacion, medicamentos que comprenden estos compuestos y su uso. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant, registration | ||
FD | Application declared void or lapsed |